Source:http://www4.wiwiss.fu-berlin.de/dailymed/resource/drugs/1802
| Predicate | Object |
|---|---|
| rdf:type | |
| rdfs:label |
Solage (Solution)
|
| dailymed-instance:dosage |
Patients require detailed instruction to obtain maximal benefits
and to understand all the precautions necessary to use this product with
greatest safety. The physician should review the Patient Medication
Guide.Apply Solag��Solution to the solar lentigines using the applicator tip
while avoiding application to the surrounding skin. Use twice daily,
morning and evening at least 8 hours apart, or as directed by a
physician. Patients should not shower or bathe the treatment areas for
at least 6 hours after application of Solag��Solution. Special caution should be taken
when applying Solag��Solution to avoid the eyes, mouth, paranasal creases, and
mucous membranes.Application of Solag��Solution may cause transitory stinging,
burning or irritation.Improvement continues gradually through the
course of therapy and should be apparent by 24 weeks. Patients should
avoid exposure to sunlight (including sunlamps) or wear protective clothing while using Solag��Solution. Data are not available to establish how or
whether Solag��Solution
is degraded (either by sunlight or by normal interior lighting)
following application to the skin.With discontinuation of Solag��Solution therapy, a
majority of patients will experience some repigmentation over time of
their lesions.Applications of larger amounts of medication or more
frequently than recommended will not lead to more rapid or better
results, and marked redness, peeling, irritation, or hypopigmentation
(abnormal lightening) of the skin may occur.Patients treated withSolag��Solution may use
cosmetics but should wait 30 minutes before applying.
|
| dailymed-instance:activeIng... | |
| dailymed-instance:activeMoi... | |
| dailymed-instance:inactiveI... | |
| dailymed-instance:genericMe... |
mequinol and tretinoin
|
| dailymed-instance:fullName |
Solage (Solution)
|
| dailymed-instance:indicatio... |
(To understand fully the indication for this product, please read
the entire INDICATIONS
AND USAGE section of the labeling).Solag��(mequinol 2%, tretinoin
0.01%) Topical Solution is indicated for the treatment of solar
lentigines.Solag��Solution should only be used under medical supervision as an adjunct to
a comprehensive skin care and sun avoidance program where the patient
should primarily either avoid the sun or use protective
clothing.Neither the safety nor effectiveness of Solag��Solution for the
prevention or treatment of melasma or postinflammatory hyperpigmentation
has been established.The efficacy of using Solag��Solution daily for
greater than 24 weeks has not been established.The local cutaneous safety of using Solag��Solution in non-Caucasians has not been adequately
established (see Clinical
Studies section).
|
| dailymed-instance:represent... | |
| dailymed-instance:routeOfAd... | |
| dailymed-instance:name |
Solage
|